Don't Miss These Top-Level Speakers
Clinicians*
John Bilezikian, MD , Chief of the Metabolic Bone Diseases Unit, Chief of the Division of Endocrinology, Professor at the College of Physicians and Surgeons, Columbia University
Steven Coutre, MD , Associate Professor of Medicine, Stanford University School of Medicine and Director of the Outpatient Hematology Clinic, Stanford Hospital
Michael Geschwind, MD, PhD , Assistant Professor, UCSF Memory and Aging Center
Frank Giles, MD , Director of Institute for Drug Development, Chairman of the Division of Hematology and Medical Oncology, University of Texas Health Sciences Center, San Antonio
Andrew Holman, MD , Associate Clinical Professor of Medicine, University of Washington, Seattle
Thomas J. Lynch, MD , Chief Hematology and Oncology, Director of the Center for Thoracic Cancers, Massachusetts General Hospital; Professor of Medicine, Harvard Medical School
Renato G. Martins, MD , Medical Director of Thoracic Oncology, Seattle Cancer Care Alliance
Barry Massie, MD , Professor of Medicine at the University of California at San Francisco, Chief Cardiology Division at San Francisco Veterans Affairs Medical Center
Michael McClung, MD , Founding Director of the Oregon Osteoporosis Center
Philip Mease, MD , Director of Seattle Rheumatology Associates, Director of the Swedish Hospital Rheumatology Clinical Research Division, Clinical Professor, University of Washington, Seattle
Richard Moss, MD , Professor of Pediatrics, Director of Cystic Fibrosis Center, Chief of the Division of Allergy - Immunology, Stanford University
Pamela Munster, MD , Associate Professor of Dept of Medicine (Hematology/Oncology), Director of Early Phase Clinical Trials Program, Associate Director of Investigational Therapeutics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Roger Porter, MD , Professor of Neurology, University of Pennsylvania
I. Jon Russell, MD, PhD , Director of the University Clinical Research Center, Associate Professor of Medicine, University of Texas Health Science Center, San Antonio
Sunil Sharma, MD , Chief of the Section of GI Oncology and Clinical Phase 1 Unit, Nevada Cancer Institute
L. Terry Spencer, MD , Director of Cystic Fibrosis Center, Director of Clinical Research, Division of Respiratory Diseases, Children's Hospital Boston
John R. Teerlink, MD , Cardiology and Internal Medicine, University of California, San Francisco
David Treiman, MD , Director, Epilepsy Center at the Barrow Neurological Institute
* *BIO is pleased to partner with Gerson Lehrman Group (GLG) for the Seventh Annual BIO Investor Forum Therapeutic Workshops. A number of the physician experts participating on these panels are members of the GLG Councils who educate and provide insight to decision makers through a wide range of consulting methods, including telephone consultations, expert surveys and seminars. For more information about GLG, please visit www.glgroup.com.
Analysts
Hany S. Awadalla , Managing Director, Healthcare Investment Banking, Collins Stewart
Reni Benjamin, PhD , Senior Biotech Analyst, Managing Director, Rodman & Renshaw LLC
Andrew L. Busser , Principal, Symphony Capital
Farah Champsi , Managing Director, Alta Partners
Corey Davis, PhD , Managing Director, Senior Specialty Pharmaceuticals Analyst, Natixis Bleichroeder
Luke Evnin, PhD , General Phartner, MPM Capital LP
Gregory K. Frykman, MD , Senior Vice President, Pharmaceutical and Biotechnology Analyst, Stanford Group Company
Howard Furst, MD , Partner, Deerfield Management
Glenn Giovannetti , Global Biotechnology Leader, Ernst & Young
William Greene, MD , General Partner, MPM Capital LP
Annette C. Grimaldi , Managing Director, Life Sciences, Jefferies & Company, Inc.
William Ho , Vice President and Senior Research Analyst, Bank of America Securities
Ed Hurwitz , Director, Alta Partners
Jason Kantor, PhD , Managing Director, RBC Capital Markets
Michael G. King, Jr , Managing Director and Director of Research, Rodman & Renshaw LLC
Ronald W. Lennox , D.Phil, Partner, CHL Medical Partners
George Milstein , Senior Managing Director, Pacific Growth Equities
Scott Morrison , Accountant, Ernst & Young
Liana Moussatos, PhD , Healthcare Research Analyst, Pacific Growth Equities
Oleg Nodelman , Portfolio Manager/Analyst, Biotechnology Value Fund, LP
Benjamin Perkins, PhD , Managing Director, Life Sciences Group, Pacific Growth Equities
Matthew Perry , Portfolio Manager, Biotechnology Value Fund, LP
Denise Pollard-Knight, PhD , Managing Director, Nomura Phase4 Ventures
Robert Rynd , Director of Biotech Corporate Advisory Services, Thomson Reuters
David Singer , Principal, Maverick Capital
Samuel P. Wertheimer, PhD , Private Equity Partner, OrbiMed Advisors LLC
Industry
Detlef Albrecht, MD , Chief Medical Officer and Senior Vice President of Drug Development, Relypsa, Inc.
David Apelian, MD, PhD, MBA , Vice President of Clinical Development and Regulatory Affairs and Chief Medical Officer, GlobeImmune
Thomas J. Bigger , President and CEO, Paratek Pharmaceuticals
Philippe Bishop, MD , Vice President of Clinical Development, Avastin, Genentech
Leslie Boyd , VP of Scientific Licensing for Worldwide Business Development, GlaxoSmithKline
Michael R. Bristow, MD, PhD, Chairman and Chief Science and Medical Officer, Arca Biopharma, Inc.
Mark Crowell , Associate Vice Chancellor for Economic Development and Technology, University of North Carolina at Chapel Hill
Elizabeth Garofalo, MD , Marinus Pharmaceuticals Inc.
Paul Hastings , President and CEO, Oncomed Pharmaceuticals
David T. Hung, MD , President, CEO and Director, Medivation, Inc.
Jamila Joseph , General Manager, Reliance Clinical Research Services
Thomas B. King , President and CEO, Alexza Pharmaceuticals
Katharine Ku , Director of the Office of Technology Licensing (OTL), Stanford University
Lori Kunkel , MD, Chief Medical Officer, Proteolix, Inc.
James Langston , Scientific Director and CEO, The Parkinson's Institute
Hugh Martin , President and CEO, Pacific Biosciences
Lynne K. Matallana , President and Founder, National Fibromyalgia Association
Jeffrey M. Ostrove, PhD , President and CEO, Ceregene, Inc.
Daniel R. Passeri , President and CEO, Curis, Inc.
Lori Rafield, PhD , Director, VaxGen, Inc.
Jeremy Springhorn, PhD , Head of Global Business Development and Corporate Strategy, Alexion Pharmaceuticals
Yael Weiss, MD, PhD , Director of Licensing and External Research, Merck Research Laboratories, Merck & Co, Inc.
Andrew A. Wolff, MD , Chief Medical Officer and Senior Vice President of Clinical Research and Development, Cytokinetics, Inc.